I've been a bit busy lately, but I wanted to record my notes on Azure Healthcare Ltd (ASX: AZV). Over the weekend I had a discussion about Azure with Motley Fool analyst Mike King, who noted that the half yearly results looked interesting. I believe the results reduce the risk of the investment (which is somewhat speculative), and I bought shares in the company on open yesterday at 27c and 27.5c. The purchase was funded by selling my remaining shares in Cryosite (ASX: CTE) at 46c, and selling 10% of my Global Health (ASX: GLH) shares at 70c, so it will be interesting to compare the investment to those two options in the future.

Edit: This company has been sold from the Hypothetical Ethical Portfolio at the closing price of $1.50 on Tuesday 25 February. At the timing of writing, I sold half my real life shares at close, and it is likely I will sell the rest tomorrow. The thesis below has broken. I sold my shares and will not buy back. I've had hysterical emails in response to this post saying things like "Big, big, Big mistake...The hugest you will probably ever make.  I would like to see you get any money back from these people." I don't appreciate the ramblings of people who have allegedly been badly burned by those involved with Affinity Education, if they do not even understand the basics of publicly traded shares. I was very promptly emailed about this company within 48 hours of publishing the thesis below, I have done further research and sold my shares. If you have been burned by these people, feel free to not send me abusive emails. The first emailer was very helpful and polite - if you can't be those things, go vent your frustration elsewhere.

My Net Fone Limited (ASX:MNF) this morning released its first half results for 2014. In the half to 31 December 2013, the company generated Net Profit After Tax of $2.37 million, and Operating Cashflow of $2.9 million. Cash sat at $3.6 million there was approximately $1.6 million more payables than receivables on the balance sheet. The company has no debt, and has paid off all its deferred consideration for past acquisitions.

The ASX All Ordinaries closed at 5,184.506 on Friday the 7th of February, 2014. Bentham IMF Limited has at times traded at a bit less than the purchase price, possibly because the company semi-lost its case against ANZ Banking Group. However, this is simply the business they're in, and it would be foolish to overreact to individual case results.

Fair warning to anyone considering buying Vmoto shares - I don't consider this company of the same class as the other companies on this website.

Tassal has had a remarkable year. The shareprice increased over 2013 from $1.43 to $3.30, an increase of 130%. Profit after tax and dividends over FY 2013 were up over 18%, despite revenue being flat. This was mainly because of the significant reduction in borrowings. A few years ago borrowings were over 60%, with the funds used to develop the salmon farm at Macquarie Harbour in western Tasmania. At the beginning of FY 2013, borrowings were an already respectable 25% of equity and reduced over the year to 18%.

I'll have to keep this note quite short, because I'm writing from Strahan in Tasmania, about to go for a walk to see the local platypus (fingers crossed). Tomorrow we'll be trekking in the Wild Rivers National Park, a place environmentalists fought hard to protect from destruction.

So I thought I should share my thoughts on the recent announcement by Energy Action (ASX: EAX).

Subscribers will know that when Codan announced their original profit downgrade, I took the opportunity to buy shares from panic sellers. At the time, I described the position as a "research position" and subsequently, I did my research. One disturbing piece of information that I found was that the Chinese may have had access to Codan's secure radio codes.

Today I’m writing about Global Health (ASX: GLH) the smallest company I’ve ever covered on this website.